News About: Pharm. Industry


Yuyu Pharm to make strategic tie-up with GSK on Imigran

Yuyu Pharm says it signed an exclusive distribution agreement with GlaxoSmithKline on July 28 to introduce Imigran (sumatriptan) tablet, an antimigraine drug. Officials from ...

Patent dispute over erythropoietin terminated

Darae patent office said that the domestic production of erythropoietin, an biotechnology based antianemic drug, may be further activated, as CJ, a local pharmaceutical firm, won the patent dispute touched off by the ...

Industry claimed no responsible for drug price slashes.

Most of local drug companies including the foreign multinational drug corporations who were members of the KRPIA (Korea Research based Pharmaceutical Industry Association) have completed to file their formal objection...

Korea's leading vaccine makers face tougher competition

Domestic major hepatitis B vaccine makers, such as Korea Green Cross and LG Life Sciences, are desperately bracing for their R&D new product strategies in the wake of falling profit margins incurred more intense compe...

Cialis to be approved from KFDA soon

Lilly Korea's Cialis for the treatment of erectile dysfunction will be approved within this week from the Korea food and Drug Administration which completed its investigation on overall status of clinical trials condu...

Sang-A Pharm changes its name into Korea Green Cross Sang-A

Recently, Sang-A Pharm changed its company name into " Korea Green Cross Sang-A," in a bid to dispel the existing image as its OTC maker which was in court receivership earlier and renew the corporate identity as a me...

High technology investment generating 3.5 times more in sales.

The Korea Health Industry Development Institute (KHIDI) has completed the R&D investment for the leading technology and medical engineering technology development projects during the past 7 years from 1995 to 2002, ge...

KPICA's P2P E-commerce program on friction with wholesalers.

The Korea Pharmaceutical Industry Cooperative Association (KPICA) is trying to set up an electronic commercial program titled "P2P (Pharmaceutical to Pharmacy)", which arouse the pharmaceutical wholesalers concerns. ...

Chong Kun Dang Bio wins patent for human insulin

Chong Kun Dang Bio announced recently that it won from Russia a patent related to a process for manufacturing a efficient human insulin precursor as the industrial scale. Noting that 2.5 billion won was spent for t...

Drug industry less interesting in OTC drug business.

Most of drug companies did not put any full efforts for the marketing development of OTC drugs compared to the prescription drug business in spite of which the OTC drug business might contribute to the business invigo...

Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.